JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $510
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Chris Schott maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $475 to $510.
July 28, 2023 | 6:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Eli Lilly and raises the price target from $475 to $510. This could potentially lead to an increase in the stock's price.
The raised price target by JP Morgan indicates a positive outlook for Eli Lilly. This could potentially lead to an increase in the stock's price as it suggests that the analyst believes the stock is undervalued at current levels.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100